Literature DB >> 19936714

Are attention lapses related to d-amphetamine liking?

Michael McCloskey1, Abraham A Palmer, Harriet de Wit.   

Abstract

RATIONALE: A rich literature suggests that both impulsiveness and drug-induced euphoria are risk factors for drug abuse. However, few studies have examined whether sensitivity to the euphoric effects of stimulants is related to attention lapses, a behavioral measure of inattention sometimes associated with impulsivity.
OBJECTIVE: The aim of the study was to examine ratings of d-amphetamine drug liking among individuals with high, moderate, and low attention lapses.
METHODS: Ninety-nine healthy volunteers were divided into three equal-sized groups based on their performance on a measure of lapses of attention. The groups, who exhibited low, medium, and high attention lapses (i.e., long reaction times) on a simple reaction time task, were compared on their subjective responses (i.e., ratings of liking and wanting more drug) after acute doses of d-amphetamine (0, 5, 10, and 20 mg).
RESULTS: Subjects who exhibited high lapses liked 20 mg d-amphetamine less than subjects who exhibited low lapses. These subjects also tended to report smaller increases in "wanting more drug" after d-amphetamine.
CONCLUSION: The findings suggest that participants who exhibit impaired attention may be less sensitive to stimulant-induced euphoria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19936714      PMCID: PMC4004179          DOI: 10.1007/s00213-009-1719-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder.

Authors:  Ralph E Tarter; Levent Kirisci; Ada Mezzich; Jack R Cornelius; Kathleen Pajer; Michael Vanyukov; William Gardner; Timothy Blackson; Duncan Clark
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

Review 2.  Dual determinants of drug use in humans: reward and impulsivity.

Authors:  Harriet de Wit; Jerry B Richards
Journal:  Nebr Symp Motiv       Date:  2004

3.  Increased impulsivity after injected alcohol predicts later alcohol consumption in rats: evidence for "loss-of-control drinking" and marked individual differences.

Authors:  C X Poulos; J L Parker; D A Lê
Journal:  Behav Neurosci       Date:  1998-10       Impact factor: 1.912

4.  Prenatal alcohol exposure causes attention deficits in male rats.

Authors:  Kathryn A Hausknecht; Ashley Acheson; Andrew M Farrar; Artur K Kieres; Roh-Yu Shen; Jerry B Richards; Karen E Sabol
Journal:  Behav Neurosci       Date:  2005-02       Impact factor: 1.912

5.  Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers.

Authors:  H deWit; J Pierri; C E Johanson
Journal:  Pharmacol Biochem Behav       Date:  1989-05       Impact factor: 3.533

6.  Factor structure of the Barratt impulsiveness scale.

Authors:  J H Patton; M S Stanford; E S Barratt
Journal:  J Clin Psychol       Date:  1995-11

7.  Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release.

Authors:  Rossella Ventura; Simona Cabib; Antonio Alcaro; Cristina Orsini; Stefano Puglisi-Allegra
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

Review 8.  Cellular and molecular mechanisms of drug dependence.

Authors:  G F Koob; F E Bloom
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

9.  Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals.

Authors:  Espen Walderhaug; Hilde Lunde; Jan E Nordvik; Nils Inge Landrø; Helge Refsum; Andres Magnusson
Journal:  Psychopharmacology (Berl)       Date:  2002-10-12       Impact factor: 4.530

10.  Dopamine transporter gene associated with diminished subjective response to amphetamine.

Authors:  David C Lott; Soo-Jeong Kim; Edwin H Cook; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

View more
  8 in total

Review 1.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

2.  Response inhibition impairments predict alcohol-induced sedation.

Authors:  Erin E Shannon; Elizabeth R Staniforth; Juliette McNamara; Kimberly A Bernosky-Smith; Anthony Liguori
Journal:  Alcohol Alcohol       Date:  2010-12-02       Impact factor: 2.826

3.  Inattention, impulsive action, and subjective response to D-amphetamine.

Authors:  Jessica Weafer; Harriet de Wit
Journal:  Drug Alcohol Depend       Date:  2013-06-18       Impact factor: 4.492

4.  Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance.

Authors:  Ava-Ann Allman; Chawki Benkelfat; France Durand; Igor Sibon; Alain Dagher; Marco Leyton; Glen B Baker; Gillian A O'Driscoll
Journal:  Psychopharmacology (Berl)       Date:  2010-07-04       Impact factor: 4.530

5.  Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention.

Authors:  Jessica Weafer; Matthew J Baggott; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2013-10-07       Impact factor: 3.157

6.  Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC.

Authors:  Conor H Murray; Zhengyi Huang; Royce Lee; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2022-02-02       Impact factor: 8.294

7.  Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine.

Authors:  K P C Kuypers; E B de Sousa Fernandes Perna; P C Dolder; S W Toennes; E L Theunissen; N L Mason; N R P W Hutten; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2018-05-31       Impact factor: 4.530

8.  Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers.

Authors:  Claire Advokat; Mindy Scheithauer
Journal:  Front Neurosci       Date:  2013-05-29       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.